What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ Evidence-Based …, 2023 - ebm.bmj.com
The COVID-19 pandemic presents substantial challenges for governments and providers
keen to provide effective treatments. The tensions between supply, uncertainty of which …
被引用次数：2 相关文章

What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
The COVID-19 pandemic presents substantial challenges for governments and providers
keen to provide effective treatments. The tensions between supply, uncertainty of which …

[引用][C] What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ evidence-based …, 2023 - pubmed.ncbi.nlm.nih.gov
What is the place in therapy for nirmatrelvir/ritonavir? What is the place in therapy for
nirmatrelvir/ritonavir? BMJ Evid Based Med. 2023 Oct;28(5):287-290. doi: 10.1136/bmjebm-2022-112064 …

[引用][C] What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ Evidence-based …, 2022 - europepmc.org
What is the place in therapy for nirmatrelvir/ritonavir? - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ Evidence-Based …, 2022 - search.proquest.com
The first available data for nirmatrelvir/ritonavir came from the EPIC-HR (Evaluation of
Protease Inhibition for COVID-19 in High-Risk Patients) trial. 3 This was a randomised …

What is the place in therapy for nirmatrelvir/ritonavir?

TC Lee, JM Pogue, EK McCreary… - BMJ Evidence-Based …, 2023 - search.proquest.com
The tensions between supply, uncertainty of which patient populations optimally benefit,
time-limited effectiveness (due to need for rapid initiation of treatment on an individual level …